News | Mammography | March 24, 2017

GE Healthcare Launches Senographe Pristina Mammography System

System is purposefully designed to help reduce pain, discomfort and anxiety for patients to improve the mammography experience

GE Healthcare, Senographe Pristina mammography system, launch, RSNA 2017, patient comfort

March 24, 2017 — GE Healthcare announced the launch of its new Senographe Pristina mammography system, designed to make breast screening more comfortable and inviting for patients.

A recent study conducted by Evans, et.al, found that painful exams explain why 25 to 46 percent1 of women failed to return for further breast imaging. The study concluded that effective pain-reducing interventions in mammography are needed to encourage more women to come in for screening. The target participation rate in Canadian organized breast cancer screening programs is 70 per cent of eligible women2. Currently all provincial programs fall below this rate2.

Senographe Pristina features a range of ergonomic features that are intentionally designed to enable patients to be more comfortable. All parts in contact with the patient's breasts, for example, have gentle, rounded corners for greater comfort. The system features comfortable armrests that relax the pectoral muscles to simplify positioning, compression and image acquisition.

Traditional mammography systems compress the breast automatically, which can be a source of considerable discomfort. Senographe Pristina features a self-compression tool that helps give women a sense of control by allowing them to manually adjust the degree of breast compression. Under the direction of a technologist, the patient can set compression to a level that feels right for them.

Taken together, these design features mean that technologists are better able to focus on precise positioning, making exams easier and faster. Poor positioning is the cause of most clinical image deficiencies that often require a rescan3.

For more information: www.gehealthcare.com

References

1. Whelehan P, Evans A, Wells M, Macgillivray S. The effect of mammography pain on repeat participation in breast cancer screening: a systematic review. Breast. 2013; 22(4):389–94.

2. Cancer Screening in Canada: An Overview of Screening Participation for Breast, Cervical and Colorectal Cancer, http://www.partnershipagainstcancer.ca

3. U.S. Food and Drug Administration http://www.fda.gov/Radiation-EmittingProducts/MammographyQualityStandardsActandProgram/FacilityScorecard/ucm495378.htm

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Therapixel Appoints Matthieu Leclerc-Chalvet as CEO
News | Artificial Intelligence | July 03, 2019
Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu...
GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

Feature | Breast Imaging | July 03, 2019 | By Greg Freiherr
Productivity and its enabler — efficiency — guided the display of products at the April...
Countless possibilities can impact the future of global healthcare and AI is the first step toward breakthrough that will change the landscape of personalized medicine
Feature | Women's Health | July 03, 2019 | By Samir Parikh
Contrary to what many people believe,...

Image courtesy of GE Healthcare

Feature | Radiology Business | July 03, 2019 | By Jeffrey Hoffmeister, M.D.
Burnout in the medical profession is not uncommon, particularly as clinicians have become more overwhelmed by growing
iCAD ProFound AI

Image courtesy of iCAD

News | Breast Imaging | June 25, 2019
Use of...